Mayinglong Pharmaceutical Group Stock Co.,Ltd.’s Net Profit Rose 1.3% in 2022

Mayinglong Pharmaceutical Group Stock Co.,Ltd. (马应龙药业集团股份有限公司) (600993.SH) reported a net profit of 480.3 million yuan in 2022, up 1.3% year-on-year.

Meanwhile, the company posted 3.5 billion yuan in revenue, up 4.4% year-on-year.

At the end of the reporting period, it had 5.1 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 28.5%.